Patent · US Active

Melanin-concentrating hormone receptor antagonists containing piperidine derivatives as the active ingredient

US7727998B2 · kind B2 · utility

12Cited by
11References
11Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 9, 2004
Grant dateJun 1, 2010
Priority date
Expiry dateSep 27, 2026

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D491/10
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides melanin-concentrating hormone receptor antagonists containing as the active ingredient piperidine derivatives represented by the general formula [I]:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.